MEDIDERMA S.L.

Mediderma S.L. specializes in single-use surgical instruments primarily for dermatological procedures. Their product line includes sterile packs of corneoabrasion heads and various needle sets (circular, linear, and square) designed for precision skin treatments. They also produce the Nanopore Stylus, a handheld device intended for controlled skin penetration in medical applications. All devices are intended for use in sterile, controlled clinical environments.

Mediderma S.L. is based in Spain, which means their devices are subject to European Union medical device regulations. Since their products are listed in the EUDAMED database, they comply with the EU’s regulatory framework, ensuring traceability and transparency for authorized devices under the Medical Device Regulation (MDR). The company’s location also implies adherence to EU standards for manufacturing, labeling, and post-market surveillance.

Mediderma S.L.’s devices are registered in the EUDAMED database, the official EU portal for medical device traceability. This registry is critical because it provides authorized stakeholders—such as healthcare providers, regulators, and national competent authorities—with verified information about the manufacturer, device details, and compliance status. Listing in EUDAMED ensures transparency and supports the traceability requirements under the EU Medical Device Regulation (MDR).

All of Mediderma S.L.’s devices fall under EU Class IIa, which indicates a moderate risk level. This classification requires conformity assessment procedures, including technical documentation review and, in some cases, involvement of a Notified Body to ensure the device meets essential safety and performance requirements. Class IIa devices are subject to stricter scrutiny than Class I but less than higher-risk classes like IIb or III, balancing regulatory oversight with practical clinical use.